View:
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
July 18, 2003
- ------------------
(Date of earliest event reported)
LABORATORY CORPORATION OF AMERICA HOLDINGS
- ------------------------------------------
(Exact name of registrant as specified in its charter)
DELAWARE 1-11353 13-3757370
-------------- ----------- --------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification
incorporation) Number)
358 SOUTH MAIN STREET, BURLINGTON, NORTH CAROLINA 27215
- -------------------------------------------------------
(Address of principal executive offices)
336-229-1127
- ------------
(Registrant's telephone number, including area code)
ITEM 9. Regulation FD Disclosure
Laboratory Corporation of America -Registered Trademark-
Holdings (LabCorp -Registered Trademark-)(NYSE:LH) announced that M. Keith
Weikel, Ph.D. has been elected to its Board of Directors, effective
July 16, 2003. Dr. Weikel, 65, is a Senior Executive Vice President
and Chief Operating Officer of Manor Care, Inc., located in Toledo, Ohio.
Dr. Weikel was selected to fill the open seat left by Dr. David Skinner
who passed away in January 2003.
Exhibits:
99.1 Press release of the Company dated July 18, 2003.
SIGNATURES
Pursuant to the requirements of the Securities and
Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the
undersigned hereunto duly authorized.
LABORATORY CORPORATION OF AMERICA HOLDINGS
------------------------------------------
(Registrant)
By:/s/ BRADFORD T. SMITH
----------------------------------
Bradford T. Smith
Executive Vice President
and Secretary
Date: July 18, 2003
Laboratory Corporation of America-Registered Trademark- Holdings
358 South Main Street
Burlington, NC 27215
Telephone: 336-584-5171
FOR IMMEDIATE RELEASE
Contact: 336-436-4855
Pamela Sherry
Shareholder Direct: 800-LAB-0401
www.labcorp.com
LABCORP-REGISTERED TRADEMARK-NAMES
M. KEITH WEIKEL, PH. D.
TO ITS BOARD OF DIRECTORS
Burlington, NC, July 18, 2003 - Laboratory Corporation of America-Registered
Trademark- Holdings (LabCorp-Registered Trademark-) (NYSE: LH) today announced
that M. Keith Weikel, Ph.D. has been elected to its Board of Directors,
effective July 16, 2003. Dr. Weikel, 65, is a Senior Executive Vice President
and Chief Operating Officer of Manor Care, Inc., located in Toledo, Ohio.
Dr. Weikel was selected to fill the open seat left by Dr. David Skinner who
passed away in January 2003.
Dr. Weikel began his career at Manor Care, Inc. in 1984 when he joined Manor
HealthCare Corporation, an operating subsidiary of Manor Care, Inc. He has
served as a director on the company's board since 1992. Throughout his
extensive career in the health care industry, Dr. Weikel has held senior level
positions with such organizations as Health Care and Retirement
Corporation of America, American Medical International, Inc. and the US
Department of Health and Human Services, where he served as the Commissioner
of Medical Services Administration. He has also played an active role with
leading medical organizations such as the American Health Care
Association. Dr. Weikel is currently a member of the Federation of American
Health Systems and the Alliance for Quality Long Term Care.
"I am pleased to inform LabCorp employees and shareholders that we have added
such an outstanding new member to our Board of Directors," said Thomas P. Mac
Mahon, LabCorp Chairman of the Board and Chief Executive Officer. "Dr. Keith
Weikel has a strong background in the day-to-day management of a large, multi-
site service organization, and possesses extensive public policy skills and
expertise in assessing health care and medical trends. We are delighted
Keith has agreed to join our board."
The first national clinical laboratory to fully embrace genomic testing,
Laboratory Corporation of America-Registered Trademark- Holdings (LabCorp-
Registered Trademark-) has been a pioneer in commercializing new diagnostic
technologies. As a national laboratory with annual revenues of $2.5
billion in 2002 and over 24,000 employees, the Company offers more than 4,000
clinical tests ranging from routine blood analyses to sophisticated molecular
diagnostics. Serving over 200,000 clients nationwide, LabCorp combines its
expertise in innovative clinical testing technology with its Centers of
Excellence. The Center for Molecular Biology and Pathology, in Research
Triangle Park, North Carolina, offers state-of-the-art molecular gene-based
testing in infectious disease, oncology and genetics. DIANON Systems, its
Anatomic Pathology Center of Excellence, is a leader in oncology and genetic
testing, and National Genetics Institute in Los Angeles is an industry leader
in developing novel, highly sensitive polymerase chain reaction (PCR) methods
for testing hepatitis C and other blood borne infectious agents. LabCorp's
Minneapolis-based ViroMed offers molecular microbial testing using real time
PCR platforms, while its Center for Esoteric Testing in Burlington,
North Carolina, performs the largest volume of specialty testing in the
network. LabCorp's clients include physicians, state and federal government,
managed care organizations, hospitals, clinics, pharmaceutical and Fortune
1000 companies, and other clinical laboratories.
Each of the above forward-looking statements is subject to change based on
various important factors, including without limitation, competitive actions
in the marketplace and adverse actions of governmental and other third-party
payors. Actual results could differ materially from those suggested by these
forward-looking statements. Further information on potential factors that
could affect LabCorp's financial results is included in the Company's Form
10-K for the year ended December 31, 2002 and subsequent SEC filings.